1st, October 2018 From September 25 to 27, the meeting organized by ASEBIO and the Junta de Andalucía brought together in Seville the largest national and international agents in the biotechnology sector. PROALT has participated in the partnering event and met during these days with investors, customers and potential commercial and technological partners. The company [...]
Photo: partnering meetings at BIO 2018. 6th, June 2018 PROALT has participated in the partnering event at BIO International Convention in Boston, MA (USA), to present the latest advances of COLODETECT, the non-invasive test in development by the company that will allow early detection of colorectal cancer (CCR) in patients affected by this disease, even [...]
14th, March 2018 BIOEUROPE SPRING 2018 is the premier springtime partnering conference for the biotechnology industry. Amsterdam, The Netherlands. 12th-14th March 2018. The company participated in the conference and partnering event to promote its activities in colorectal cancer diagnostic and therapeutic fields, highlighting the latest progresses. Investors had the chance to update about the of [...]
Photo: Dr. Thomas Zürcher, R&D Project Leader, during PROALT presentation in investors session: Novel approaches for the diagnosis and treatment of colorectal cancer. 26th, February 2018 PROTEIN ALTERNATIVES attended the 11th Annual European Life Sciences CEO Forum & Exhibition for Partnering & Investing in Biotech & Pharma Industry. The event was organized by Sachs Associates [...]
Photo: Dr. Juan I. Imbaud during its presentation. 14th, November 2017 PROALT was nominated for the Innovation Award and presented its colorectal cancer diagnostic and therapeutic projects at the eHealth Venture Summit 2017 in November 14th. The competition took place as part of MEDICA HEALTH FORUM in Düsseldorf (Germany) from 13-16 November. The eHealth Venture [...]
Photo: Dr. Juan I. Imbaud. Poster session B47 26th, October 2017 PROALT attends AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications. During the event, organized in Philadelphia (PA) from 26th to 30th October, Dr Juan Ignacio Imbaud, the company Director, exposed a poster that showed the latest results of [...]
22nd, June 2017 PROALT was present at BIO 2017 International Convention in San Diego CA (USA) from 19 to 22 June. The company exhibited all its business activities in a booth located within the Spanish pavilion, where several contacts with companies' representatives were celebrated, and also participated in the partnering area (business forum) to have [...]
3rd, October 2016 PROALT has attended BIOSPAIN 2016. This year's event has been held from 28th to 31st September 2016 in Bilbao (Spain). PROALT participated with a booth at the exhibition area of BioSpain. PROALT also met other attendees during the business partnering and presented its business project at the Investment Forum. [...]
10th, June 2016 PROALT has participated in BIO International Convention 2016. The event has been held in San Francisco (United States) from 6 to 9 June 2016 . The Spanish Pavillion was organized by ICEX (Spain Trade and Investment) and The Spanish Trade Commission in Chicago, and brought together other 52 companies and Spanish biotech [...]
10th, June 2016 PROALT has been selected by Enterprise Europe Network (EEN) as a successfully funded company and invited to present its ColoDetect project in the European Commission's booth #5977 at BIO International Convention trade fair. The event, hold in San Francisco (United States), took place on Wednesday 8 June 2016. PROALT presented the key [...]
Human RPL37A (60S ribosomal protein L37a) recombinant protein
€150,00 – €2.820,00
Human SPRY1 (Protein sprouty homolog 1) recombinant protein
€150,00 – €2.820,00
Human DCTPP1 (dCTP pyrophosphatase 1) recombinant protein
€150,00 – €2.820,00
Copyright ©2020 Protein Alternatives SL. All rights reserved | Legal Notice & Privacy Policy
